KRAS G12D-Mutant Advanced or Metastatic Pancreatic Cancer in the First-line Setting
1 clinical trials · Condition
◉ Watch KRAS G12D-Mutant Advanced or Metastatic Pancreatic Cancer in the First-line Setting
| Record | Firm | Date |
|---|---|---|
| HRS 4642 Injection Combined With AG Versus Placebo Combined With AG Therapy in First-Line Advanced or Metastatic Pancreatic Cancer (NCT07232875) | Jiangsu HengRui Medicine Co., Ltd. | 2025-11-21 |
Track KRAS G12D-Mutant Advanced or Metastatic Pancreatic Cancer in the First-line Setting automatically
Every clearance here is in the API, with alerts when new ones post.